{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:53:49Z","timestamp":1773658429988,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Lab Res"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1007\/s005990050046","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T23:33:36Z","timestamp":1070408016000},"page":"201-210","source":"Crossref","is-referenced-by-count":23,"title":["Laboratory diagnosis of von Willebrand disease"],"prefix":"10.1007","volume":"28","author":[{"given":"A.","family":"Veyradier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fressinaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"284201_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0038-1646168","volume":"70","author":"D Meyer","year":"1993","unstructured":"Meyer D, Girma JP. von Willebrand factor: structure and function. Thromb Haemost 1993; 70: 99.","journal-title":"Thromb Haemost"},{"key":"284201_CR2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9343(97)00239-8","volume":"103","author":"A Tefferi","year":"1997","unstructured":"Tefferi A, Nichols WL. Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis and treatment. Am J Med 1997; 103: 536.","journal-title":"Am J Med"},{"key":"284201_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","volume":"71","author":"JE Sadler","year":"1994","unstructured":"Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520.","journal-title":"Thromb Haemost"},{"key":"284201_CR4","first-page":"223","volume":"10","author":"IM Nilsson","year":"1963","unstructured":"Nilsson IM, Magnusson S, Borchgrevinck C. The Duke and Ivy methods for determination of the bleeding time. Thromb Diath Haemorrh 1963; 10: 223.","journal-title":"Thromb Diath Haemorrh"},{"issue":"Suppl 2","key":"284201_CR5","first-page":"106","volume":"21","author":"SK Kundu","year":"1995","unstructured":"Kundu SK, Heilmann E, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an \u201cin vitro\u201d platelet function analyzer-PFA-100\u2122. Semin Thromb Hemost 1995; 21 Suppl 2: 106.","journal-title":"Semin Thromb Hemost"},{"key":"284201_CR6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","volume":"91","author":"E Fressinaud","year":"1998","unstructured":"Fressinaud E, Veyradier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D. Screening for von Willebrand disease with a new analyzer utilizing high shear stress. A study of 60 cases. Blood 1998; 91: 1325.","journal-title":"Blood"},{"key":"284201_CR7","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","volume":"69","author":"JC Gill","year":"1987","unstructured":"Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691.","journal-title":"Blood"},{"key":"284201_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI106480","volume":"50","author":"TS Zimmerman","year":"1971","unstructured":"Zimmerman TS, Ratnoff OD, Powell AE. Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand disease. J Clin Invest 1971; 50: 244.","journal-title":"J Clin Invest"},{"key":"284201_CR9","first-page":"926","volume":"93","author":"JP Girma","year":"1979","unstructured":"Girma JP, Ardaillou N, Meyer D, Lavergne JM, Larrieu MJ. Fluid phase immunoradiometric assay for the detection of qualitative abnormalities of factor VIII\/vWF in variants of von Willebrand disease. J Lab Clin Med 1979; 93: 926.","journal-title":"J Lab Clin Med"},{"key":"284201_CR10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00365518709168882","volume":"47","author":"J Ingerslev","year":"1987","unstructured":"Ingerslev J. A sensitive ELISA for von Willebrand factor (vWF: Ag). Scand J Clin Lab Invest 1987; 47: 143.","journal-title":"Scand J Clin Lab Invest"},{"key":"284201_CR11","first-page":"306","volume":"34","author":"DE Mac Farlane","year":"1975","unstructured":"Mac Farlane DE, Stibbe K, Kirby EP, Zucker MB, Grant RA, Mc Pherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306.","journal-title":"Thromb Diath Haemorrh"},{"key":"284201_CR12","first-page":"73","volume":"20","author":"RD Wright","year":"1990","unstructured":"Wright RD, Krauss JS. A comparison of two macroscopic platelet agglutination assays for von Willebrand factor. Ann Clin Lab Sci 1990; 20: 73.","journal-title":"Ann Clin Lab Sci"},{"key":"284201_CR13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V45.3.403.403","volume":"45","author":"HJ Weiss","year":"1975","unstructured":"Weiss HJ. Abnormalities of factor VIII and platelet aggregation \u2014 use of ristocetin in diagnosing the von Willebrand disease syndrome. Blood 1975; 45: 403.","journal-title":"Blood"},{"key":"284201_CR14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V57.6.1140.1140","volume":"57","author":"ZM Ruggeri","year":"1981","unstructured":"Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII\/von Willebrand factor. Blood 1981; 57: 1140.","journal-title":"Blood"},{"key":"284201_CR15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0049-3848(90)90129-Z","volume":"59","author":"F Rodeghiero","year":"1990","unstructured":"Rodeghiero F, Castaman G, Tosetto A, Lattuada A, Mannucci PM. Platelet von Willebrand factor assay: results using two methods for platelet lysis. Thromb Res 1990; 59: 259.","journal-title":"Thromb Res"},{"key":"284201_CR16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0038-1647310","volume":"64","author":"JP Girma","year":"1990","unstructured":"Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Thromb Haemost 1990; 64: 326.","journal-title":"Thromb Haemost"},{"key":"284201_CR17","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V91.5.1572","volume":"91","author":"CA Hillery","year":"1998","unstructured":"Hillery CA, Mancuso DJ, Sadler JE, Ponder JW, Jozwiak MA, Christopherson PA, Gill JC, Scott JP, Montgomery RR. Type 2M von Willebrand disease. F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin \u2014 but not botrocetin \u2014 mediated binding of von Willebrand factor to platelets. Blood 1998; 91: 1572.","journal-title":"Blood"},{"key":"284201_CR18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/00313029309084791","volume":"25","author":"EJ Favaloro","year":"1993","unstructured":"Favaloro EJ, Grispo L, Dinale A, Berndt M, Koutts J. von Willebrand disease. Laboratory investigation using an improved functional assay for von Willebrand factor. Pathology 1993; 25: 152.","journal-title":"Pathology"},{"key":"284201_CR19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","volume":"74","author":"M Nishino","year":"1989","unstructured":"Nishino M, Girma JP, Rothschild C, Fressinaud E, Meyer D. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989; 74: 1591.","journal-title":"Blood"},{"key":"284201_CR20","first-page":"704","volume":"103","author":"DR Mc Caroll","year":"1984","unstructured":"Mc Caroll DR, Ruggeri ZM, Montgomery RR. Correlation between circulating levels of von Willebrand\u2019s antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand disease. J Lab Clin Med 1984; 103: 704.","journal-title":"J Lab Clin Med"},{"key":"284201_CR21","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","volume":"91","author":"H Mohri","year":"1998","unstructured":"Mohri H, Motomura S, Kanamori H, Matsuzaki M, Watanabe S, Maruta A, Kodama F, Okubo T. Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 1998; 91: 3623.","journal-title":"Blood"},{"key":"284201_CR22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1657568","volume":"78","author":"D Meyer","year":"1997","unstructured":"Meyer D, Fressinaud E, Gaucher C, Lavergne JM, Hilbert L, Ribba AS, Jorieux S, Mazurier C and the INSERM Network on Molecular Abnormalities in von Willebrand disease. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. Thromb Haemost 1997; 78: 451.","journal-title":"Thromb Haemost"},{"key":"284201_CR23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2141.1990.tb07879.x","volume":"76","author":"GR Standen","year":"1990","unstructured":"Standen GR, Bignell P, Bowen DJ, Peake IR, Bloom AL. Family studies in von Willebrand\u2019s disease by analysis of restriction fragment length polymorphisms and an intragenic variable number tandem repeat (VNTR) sequence. Br J Haematol 1990; 76: 242.","journal-title":"Br J Haematol"},{"key":"284201_CR24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0038-1648835","volume":"72","author":"DJ Mancuso","year":"1994","unstructured":"Mancuso DJ, Tuley EA, Castillo R, Bosch N de, Mannucci PM, Sadler JE. Characterization of partial gene deletions in type III von Willebrand disease with alloantibody inhibitors. Thromb Haemost 1994; 72: 180.","journal-title":"Thromb Haemost"},{"key":"284201_CR25","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(93)91070-3","volume":"341","author":"JC Eikenboom","year":"1993","unstructured":"Eikenboom JC, Reitsma PH, Peerlinck KM, Briet E. Recessive inheritance of von Willebrand\u2019s disease type I. Lancet 1993; 341: 982.","journal-title":"Lancet"},{"key":"284201_CR26","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","volume":"88","author":"JC Eikenboom","year":"1996","unstructured":"Eikenboom JC, Matsushita T, Reitsma PH, Tuley EA, Castaman G, Bri\u2019t E, Sadler JE. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 1996; 88: 2433.","journal-title":"Blood"},{"key":"284201_CR27","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","volume":"267","author":"SE Lyons","year":"1992","unstructured":"Lyons SE, Bruck ME, Bowie EJN, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 1992; 267: 4424.","journal-title":"J Biol Chem"},{"key":"284201_CR28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","volume":"84","author":"C Gaucher","year":"1994","unstructured":"Gaucher C, Dieval J, Mazurier C. Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease. Blood 1994; 84: 1024.","journal-title":"Blood"},{"key":"284201_CR29","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","volume":"93","author":"R Schneppenheim","year":"1996","unstructured":"Schneppenheim R, Brassard J, Krey S, Budde U, Kunicki TJ, Holmberg L, Ware J, Ruggeri ZM. Defective dimerization of von Willebrand factor subunits due to a Cys \u2192 Arg mutation in type IID von Willebrand disease. Proc Natl Acad Sci U S A 1996; 93: 3581.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"284201_CR30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","volume":"71","author":"PM Mannucci","year":"1988","unstructured":"Mannucci PM, Lombardi R, Castaman G, Dent JA, Lattuada A, Rodeghiero F, Zimmerman TS. von Willebrand disease \u201cVicenza\u201d with larger-than-normal (supranormal) von Willebrand factor multimers. Blood 1988; 71: 65.","journal-title":"Blood"},{"key":"284201_CR31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1365-2516.1998.00282.x","volume":"4","author":"R Schneppenheim","year":"1998","unstructured":"Schneppenheim R, Federici AB, Budde U, Castaman G, Drewke E, Krey S, Mannucci PM, Riesen G, Rodeghiero F, Zieger B, Zimmerman R. Candidate mutation for von Willebrand disease type 2M Vicenza in Italian and German patients (abstract). Haemophilia 1998; 4: 282.","journal-title":"Haemophilia"},{"key":"284201_CR32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","volume":"68","author":"HJ Weiss","year":"1986","unstructured":"Weiss HJ, Sussman II. A new von Willebrand variant (type I, New York). Increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers. Blood 1986, 68: 149.","journal-title":"Blood"},{"key":"284201_CR33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","volume":"68","author":"L Holmberg","year":"1986","unstructured":"Holmberg L, Berntorp E, Donner M, Nilsson IM. von Willebrand\u2019s disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma. Blood 1986; 68: 668.","journal-title":"Blood"}],"container-title":["International Journal of Clinical & Laboratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990050046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s005990050046\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s005990050046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T09:43:24Z","timestamp":1623577404000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s005990050046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["284201"],"URL":"https:\/\/doi.org\/10.1007\/s005990050046","relation":{},"ISSN":["0940-5437","1434-4467"],"issn-type":[{"value":"0940-5437","type":"print"},{"value":"1434-4467","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}